Enoblituzumab (Anti-B7-H3 / CD276)

製品コード：A2626         Batch: A262602

印刷

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

製品説明

CAS No. 1353485-38-7
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 4.37mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。